NCT00946725View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

November 30, 2000

Study Completion Date

November 30, 2000

Conditions
AnginaHypertension
Interventions
DRUG

Atenolol (Tenormin) 100 mg Tablets Zeneca (Astra Zeneca Pharmaceutical)

DRUG

Atenolol 100 mg Tablets (Geneva Pharmaceutical, Inc.)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY